Katrina’s Blog™
Insightful News and Commentary
On leadership, product innovation, talent cultivation, and ecosystem development across drugs, devices, diagnostics, and digital health tools.
Join us as we explore the latest trends and share expert insights to help you navigate the ever-evolving landscape of healthcare innovation.
Let’s embark on this journey of transformation together!

Use Quality Principles to Blast Past Compliance Into Excellence
Jan 30, 2020 | Product Development
The FDA has long supported a quality approach to improve the safety of medical products. The Case for Quality captures the continuing efforts to encourage medical device manufacturers to apply quality principles to their products and operations. The program was...

The Increased Role of International Harmonization Efforts in FDA
Jan 28, 2020 | Product Development
It appears to me that the FDA is increasing its use of medical products harmonization document as a source for regulatory guidance in recent years. For example, during the Pharmaceutical Quality Symposium in October, Tara Groen and Rapti Maudurawe of the FDA noted the...

The Compliance Program Guidance Manual Guides Inspections
Jan 23, 2020 | Product Development, Uncategorized
Similar to the MAPP discussed in a previous post, the Compliance Program Guidance Manual (CPGM) contains the instructions used by FDA personnel to perform the agency’s compliance work. Unlike the MAPP, the instructions in the CPGM are more like FDA guidance in that...

Understanding CDER Through Its Policies and Procedures
Jan 21, 2020 | Medicine, Product Development
An organization with a robust quality system will have established policies and procedures, so it should be no surprise that CDER has a full set. By law, these must be available to the public, so they have been published on the CDER website as the CDER Manual of...
Cybersecurity for Medical Devices Part 2
Jan 16, 2020 | Medical Products, Product Development
Conduct Your Risk Assessment Using the CVSS Standard Management of cybersecurity across the lifecycle of a medical device includes repeat assessments of the device’s vulnerabilities, categorization of their severity, and prioritizing risk mitigation and controls. The...
Categories
Latest Posts
Outbreak! Combating the 2019-Novel Coronavirus (COVID-19)
Apr 14, 2020 | COVID
Chapter 11 – CDER Creates a Single Site for Its COVID-19 Response Activities So much new information is being released daily by the FDA in response to the COVID-19 outbreak that it can be hard to keep track of the latest developments or current guidance. Some...
Setting Drug Expiration Dates
Apr 9, 2020 | Medical Products, Medicine, Product Development
Have you ever wondered how the expiration date is determined for a pharmaceutical product you’ve used? Whether prescription or over the counter, all medications have their expiration dates determined through a stability program in which batches of the product are held...
Outbreak! Combating the 2019-Novel Coronavirus (COVID-19)
Apr 7, 2020 | COVID
Chapter 10 – Are Your Clinical Trials Impacted by COVID-19? Because I spend a lot of time thinking about the approval process for new medical products, I had already begun to consider the impact of travel and access restrictions on the conduct of clinical trials....
Outbreak! Combating the 2019-Novel Coronavirus (COVID-19)
Apr 2, 2020 | COVID
Chapter 9 – Preparing for an Epidemic Here’s a Ted Talk from 2015 by Bill Gates which presents a strikingly (though not surprisingly) prescient look at the ‘next epidemic’. What I like best about this talk are the preparedness ideas he presents. I’ve already...